Barcelona-based DeepUll raised €50 million in Series C funding to validate UllCORE, a rapid sepsis diagnostic tool. The test identifies 95% of sepsis pathogens within an...
Grifols, a company that specializes in the production of plasma derivatives, will supply the Catalan Institute of Health (ICS) with 500,000 rapid tests for detecting COVID-19....